Ignite Creation Date:
2024-05-06 @ 2:22 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02034981
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2013-10-16
Brief Title:
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK MET or ROS1
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-16
First Submit QC Date:
January 10 2014
Study First Post Date:
2014-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-26
Last Update Post Date:
2024-02-28
Last Update Post Date Type:
ACTUAL